Sponsor pipeline

German CLL Study Group clinical trial pipeline

Get alerts when German CLL Study Group's trials change

6 active trials 4 recruiting 2 Phase 3 2 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-21
Primary completion pushed: 2026-08 → 2027-08
Completion pushed: 2026-08 → 2027-08
NCT04271956 Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without… · Phase 2
2026-08-21
Primary completion pushed: 2026-12 → 2027-02
Completion pushed: 2026-12 → 2027-02
NCT04515238 Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib… · Phase 2

Active trials by phase

Phase 2
2
Phase 3
2
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05197192 A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and… Chronic Lymphocytic Leukemia Recruiting 2026-08-20
NCT04608318 Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus… Chronic Lymphoid Leukemia Active, Not Recruiting 2026-04-30
Phase 2
NCT04271956 Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without… Richter Transformation Recruiting 2026-08-20
NCT04515238 Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib… Chronic Lymphoid Leukemia Active, Not Recruiting 2026-08-20
Not specified
NCT06792994 A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact… Chronic Lymphocytic Leukemia Recruiting 2026-04-30
NCT02863692 Registry of the German CLL Study Group CLL Recruiting 2025-12-08

Disease areas by active trials

Leukemia (5) · Chronic Lymphocytic Leukemia (CLL) (3)

Get alerts when German CLL Study Group's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free